Array BioPharma Inc. (ARRY) Stock Quote

Detailed Quote for Array BioPharma Inc. (ARRY) 
$ 2.66 r      0.06 (+2.31%) Volume: 1.23 m 4:00 PM EST Feb 10, 2012
After Hours:  $ 2.69   0.03 (+1.13%) Volume: 4.59 k 4:05 PM EST Feb 10, 2012
Today 5d 1m 3m 1y more
Last Price
2.66
Change $
0.06
Change %
2.31%
Tick
N/A
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
2.59
High
2.72
Low
2.55
Prev Close
2.60
Last Trade
2/10/12
Volume
1.23 m
52 Wk Hi
3.41
52 Wk Low
1.58
Market Cap
163.73 m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
61,553,615
EPS (TTM)
-0.71
PE Ratio
N/A
Exchange
NSD
News and Media for Array BioPharma Inc.  (ARRY) 
Sector News | Topic News
News for ARRY
Thu, Feb 09, 2012
5:30 PM Array BioPharma to Present at the Leerink Swann Global Healthcare Conference - Business Wire
9:00 AM Array BioPharma Announces Proposed Public Offering of Common Stock - Business Wire
Wed, Feb 08, 2012
4:01 PM Array BioPharma Announces Proposed Public Offering of Common Stock - Business Wire
Mon, Jan 30, 2012
4:35 PM Array BioPharma Names Gwen A. Fyfe, M.D. to Board of Directors - Business Wire
4:30 PM Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2012 - Business Wire
Mon, Jan 23, 2012
3:00 PM Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2012 on January 30, 2012 - Business Wire
Mon, Jan 16, 2012
8:00 PM Array BioPharma's Chief Executive Officer Robert E. Conway Resigns - Business Wire
Wed, Jan 04, 2012
5:00 PM Array BioPharma to Present at the 30th Annual J.P. Morgan Healthcare Conference - Business Wire
Sun, Dec 11, 2011
9:01 PM ARRY-614 Demonstrates Positive Single Agent Activity in Patients with Myelodysplastic Syndromes - Business Wire
9:00 PM ARRY-520 Demonstrates Durable Single-Agent Activity in Patients with AdvancedĀ Multiple Myeloma - Business Wire
Thu, Dec 01, 2011
10:00 AM Array BioPharma to Host Analyst and Investor Day Featuring Distinguished Clinical Investigators - Business Wire
Tue, Nov 29, 2011
9:00 AM Array Biopharma to Present Clinical Data on ARRY-520, a KSP Inhibitor, and ARRY-614, a Dual p38/Tie2 Inhibitor, at theĀ 2011 American Society of Hematology Annual Meeting - Business Wire
Thu, Nov 17, 2011
12:30 PM Array BioPharma to Present at the Piper Jaffray Health Care Conference - Business Wire
Mon, Oct 05, 2009
8:03 AM Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors - Canada Newswire
More News for ARRY >>

Tags for Array BioPharma Inc.

Research stocks or mutual funds related to Array BioPharma Inc. by keywords or tags. Find companies that have a similar focus to ARRY. The keywords below have been associated to ARRY by either user submission or electronic means.

pharmaceutical articles biotech research pharmaceuticals research biopharma pharmaceutical branding biotech news biotechnology industry news pharmaceutical publication biotechnology news biotech conference pharmaceutical market generic pharmaceutical siebel pharma pharmaceutical research and development abbott pharmaceutical pharma marketing pharmaceutical industry marketing pharma newsletter pharmaceutical software pharma license pharmaceutical supply chain novartis pharmaceuticals pharmaceutical cro pharma companies pharma consulting pharmaceutical sales pharmaceutical conferences pharma pharmaceutical distributors pharmaceutical development pharmaceutical reports pharmaceutical magazine biotech pharma product development pharma r&d pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical conference pharmaceutical manufacturing pharmaceutical formulation pharma reports pharmaceutical article pfizer pharmaceuticals pharma info contract pharmaceutical pharmaceutical consulting pharmaceutical events pharmaceutical industry elan pharmaceutical biotech industry